Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Christine A. Shaw, PhD

Senior Director
Moderna, Inc.

Disclosure(s): Moderna, Inc.: Salary, Stocks/Bonds

Poster(s):

234 - Safety and Immunogenicity of mRNA-1345, an mRNA-Based RSV Vaccine in Younger and Older Adult Cohorts: Results from a Phase 1, Randomized Clinical Trial
Thursday, October 20, 2022
12:15 PM – 1:30 PM US ET